Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria.
Schmitt EK, Ndayisaba G, Yeka A, Asante KP, Grobusch MP, Karita E, Mugerwa H, Asiimwe S, Oduro A, Fofana B, Doumbia S, Su G, Csermak Renner K, Venishetty VK, Sayyed S, Straimer J, Demin I, Barsainya S, Boulton C, Gandhi P. Schmitt EK, et al. Among authors: grobusch mp. Clin Infect Dis. 2022 May 30;74(10):1831-1839. doi: 10.1093/cid/ciab716. Clin Infect Dis. 2022. PMID: 34410358 Free PMC article. Clinical Trial.
Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa.
Ndayisaba G, Yeka A, Asante KP, Grobusch MP, Karita E, Mugerwa H, Asiimwe S, Oduro A, Fofana B, Doumbia S, Jain JP, Barsainya S, Kullak-Ublick GA, Su G, Schmitt EK, Csermak K, Gandhi P, Hughes D. Ndayisaba G, et al. Among authors: grobusch mp. Malar J. 2021 Dec 20;20(1):478. doi: 10.1186/s12936-021-04009-1. Malar J. 2021. PMID: 34930267 Free PMC article. Clinical Trial.
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children.
Mombo-Ngoma G, Oyakhirome S, Ord R, Gabor JJ, Greutélaers KC, Profanter K, Greutélaers B, Kurth F, Lell B, Kun JF, Issifou S, Roper C, Kremsner PG, Grobusch MP. Mombo-Ngoma G, et al. Among authors: grobusch mp. Malar J. 2011 May 14;10:123. doi: 10.1186/1475-2875-10-123. Malar J. 2011. PMID: 21569596 Free PMC article. Clinical Trial.
Classification of Rhinoentomophthoromycosis into Atypical, Early, Intermediate, and Late Disease: A Proposal.
Blumentrath CG, Grobusch MP, Matsiégui PB, Pahlke F, Zoleko-Manego R, Nzenze-Aféne S, Mabicka B, Sanguinetti M, Kremsner PG, Schaumburg F. Blumentrath CG, et al. Among authors: grobusch mp. PLoS Negl Trop Dis. 2015 Oct 1;9(10):e0003984. doi: 10.1371/journal.pntd.0003984. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26426120 Free PMC article.
A comparison of different scores for diagnosis and mortality prediction of adults with sepsis in Low-and-Middle-Income Countries: a systematic review and meta-analysis.
Adegbite BR, Edoa JR, Ndzebe Ndoumba WF, Dimessa Mbadinga LB, Mombo-Ngoma G, Jacob ST, Rylance J, Hänscheid T, Adegnika AA, Grobusch MP. Adegbite BR, et al. Among authors: grobusch mp. EClinicalMedicine. 2021 Oct 30;42:101184. doi: 10.1016/j.eclinm.2021.101184. eCollection 2021 Dec. EClinicalMedicine. 2021. PMID: 34765956 Free PMC article.
Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research.
Schnyder JL, de Jong HK, Schlagenhauf P, Borrmann S, Hanscheid T, Grobusch MP. Schnyder JL, et al. Among authors: grobusch mp. Travel Med Infect Dis. 2022 Sep-Oct;49:102365. doi: 10.1016/j.tmaid.2022.102365. Epub 2022 May 31. Travel Med Infect Dis. 2022. PMID: 35661741 Free article. Review.
589 results